HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.

AuthorsM Magni, M Di Nicola, C Carlo-Stella, P Matteucci, L Devizzi, C Tarella, F Benedetti, M Martelli, C Patti, G Parvis, A Rambaldi, T Barbui, A M Gianni
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 43 Issue 6 Pg. 509-11 (Mar 2009) ISSN: 1476-5365 [Electronic] England
PMID18955979 (Publication Type: Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
Topics
  • Adult
  • Aged
  • Antibodies, Monoclonal (pharmacology)
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Combined Modality Therapy (methods)
  • Female
  • Follow-Up Studies
  • Humans
  • Immunotherapy (methods)
  • Lymphoma, Mantle-Cell (drug therapy)
  • Male
  • Middle Aged
  • Rituximab
  • Stem Cell Transplantation (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: